ΔΗΜΟΣΙΕΥΣΕΙΣ
Η νευρολόγος Μαριάνθη Μπρέζα που διατηρεί ιατρείο στην Παλλήνη
- έχει μεγάλο ακαδημαϊκό-ερευνητικό έργο
- έχει συμμετάσχει σε πολυάριθμα διεθνή ερευνητικά projects και consortium panels
- αριθμεί πάνω από 100 ανακοινώσεις-ομιλίες σε διεθνή και ελληνικά συνέδρια και πάνω από 50 ξενόγλωσσες δημοσιεύσεις στο pubmed εκ των οποίων και στο περιοδικό υψηλού δείκτη απήχησης "BRAIN".
List of Publications
1. DS Lynch, G Koutsis, A Tucci, M Panas, M Baklou, M Breza, G Karadima, H Houlden. Hereditary spastic paraplegia in Greece: Characterisation of a previously unexplored population using next generation sequencing. Eur J Human Genet 2016;24(6):857-863.
https://doi.org/10.1038/ejhg.2015.200
2. G Koutsis, A Kladi, M Breza, G Karadima, M Panas. Spinobulbar muscular atrophy (Kennedy’s disease): a rare diagnosis in the Greek population. J Neurol Sci 2015;359:4.
https://doi.org/10.1016/j.jns.2015.10.021
3. G Koutsis, G Velonakis, M Breza, E Karavasilis, T Zambelis, M Panas. Neck flexion-induced finger tremor: a novel observation in Hirayama disease. J Neurol Sci 2016;364:42-44.
https://doi.org/10.1016/j.jns.2016.03.012
4. A Bougea, C Koros, M Stamelou, AM Simitsi, N Papagiannakis, R Antonellou, D Papadimitriou, M Breza, K Tasios, S Fragkiadaki, X Geronicola Trapali, M Bourbouli, G Koutsis, S Papageorgiou, E Kapaki, GP Paraskevas, L Stefanis. Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene. Parkinsonism Relat Disord 2017;35:82-87.
https://doi.org/10.1016/j.parkreldis.2016.12.002
5. G Koutsis, M Breza, ME Evangelopoulos, M Anagnostouli, E Andreadou, G Karagiorgis, P Kokotis, C Kilidireas, N Karandreas. Spastic paretic hemifacial contracture as a presenting feature of multiple sclerosis. Mult Scler Relat Disord 2017;13:112-115.
6. M Breza, G Koutsis, G Karadima, C Potagas, Ch Kartanou, SG Papageorgiou, GP Paraskevas, E Kapaki, L Stefanis, M Panas. The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia. Neurosci Lett 2018;672:136-139.
https://doi.org/10.1016/j.neulet.2017.12.015
7. M Breza, G Koutsis, G Karadima, C Potagas, Ch Kartanou, SG Papageorgiou, GP Paraskevas, E Kapaki, L Stefanis, M Panas. The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia. Neurosci Lett 2018;672:136-139.
https://doi.org/10.1080/21678421.2017.1400070
8. M Breza, N Smyrni, G Koutsis, E Anagnostou, J Tzartos, G Velonakis, C Kokkinis, C Kilindireas, A Papavasiliou, C Kotsalis. Ocular flutter as presenting manifestation of pediatric MOG antibody-associated demyelination: A Case Report. Mult Scler J 2019;25:122-125. Clinical Commentary: Unusual presentations of MOG antibody-associated central nervous system demyelination: Expanding the spectrum. Ρ. Marignier Mult Scler J. DOI: 10.1177/1352458518804127.
https://doi.org/10.1177/1352458518771872With
9. M Breza, G Koutsis. Kennedy’s disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. J Neurol 2019;266:566-573.
https://doi.org/10.1007/s00415-018-8968-7
10. G Koutsis, M Breza, G Velonakis, J Tzartos, D Kasselimis, C Kartanou, E Karavasilis, D Tzanetakos, M Anagnostouli, E Andreadou, M-E Evangelopoulos, C Kilidireas, C Potagas, M Panas, G Karadima. X-linked Charcot-Marie-Tooth disease and multiple sclerosis: emerging evidence for an association. J Neurol Neurosurg Psychiatry 2019;90:187-194.
http://dx.doi.org/10.1136/jnnp-2018-319014
11. GZ Kontogeorgiou, K Nikolaou, C Kartanou, M Breza, M Panas, G Karadima*, G Koutsis*. Mutational screening of the SH3TC2 gene in Greek patients with suspected demyelinating recessive Charcot-Marie-Tooth disease reveals a varied and unusual phenotypic spectrum. J Periph Nerv Syst 2019;24:125-130.
12. S Varvaressos, M Breza, S Maroussi S, M Printzou, A Georgoulis, E Papageorgiou, C Kartanou, G Karadima, G Tagaris, G Koutsis, J Tzartos. Complex neurological phenotype in a C9ORF72-positive patient with high titer anti-GAD antibodies: neuroimmunology meets neurogenetics. Eur J Neurol 2019;26:e73-e74.
https://doi.org/10.1111/ene.13926
13. E Anagnostou, A Zachou, M Breza, A Kladi, G Karadima, G Koutsis. Disentangling balance impairments in spinal and bulbar muscular atrophy. Neurosci Lett 2019;705:94-98.
https://doi.org/10.1016/j.neulet.2019.04.044
14. D Katsimpouris, C Kartanou, M Breza, M Panas, G Koutsis, G Karadima. Screening for spinocerebellar ataxia type 36 (SCA36) in the Greek population. J Neurol Sci 2019;402:131-132.
https://doi.org/10.1016/j.jns.2019.05.022
15. M Breza, G Koutsis, J Tzartos, G Velonakis, ME Evangelopoulos, D Tzanetakos, K Karageorgou, G Angelopoulou, D Kasselimis, C Potagas, M Anagnostouli, L Stefanis, C Kilidireas. MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: a case for expanding anti-MOG testing? Mult Scler Relat Disord 2019;33:67-69.
https://doi.org/10.1016/j.msard.2019.05.021
16. V Chelban, MP Wilson, J Warman Chardon, J Vandrovcova, MN Zanetti, E Zamba-Papanicolaou, S Efthymiou, S Pope, MR Conte, G Abis, Y-T Liu, E Tribollet, NA Haridy, JA Botía, M Ryten, P Nicolaou, A Minaidou, K Christodoulou, KD Kernohan, A Eaton, M Osmond, Y Ito, P Bourque, JEC Jepson, O Bello, F Bremner, C Cordivari, MM Reilly, Ma Foiani, A Heslegrave, H Zetterberg, SJR Heales, NW Wood, JE Rothman, KM Boycott, PB Mills, PT Clayton, H Houlden PhD for the Care4Rare Canada Consortium and the SYNaPS Study Group. Μember of SYNaPS Study Group. PDXK mutations cause polyneuropathy responsive to PLP supplementation. Ann Neurol 2019;86:225-240.
17. V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, R Maroofian, G Heimer, L Burglen, S Valence, E Torti, M Hacke, J Rankin, H Tariq, E Colin, V Procaccio, P Striano, K Mankad, A Lieb, S Chen, L Pisani, C Bettencourt, R Männikkö, A Manole, A Brusco, E Grosso, GB Ferrero, J Armstrong-Moron, S Gueden, O Bar-Yosef, M Tzadok, KG Monaghan, T Santiago- Sim, RE Person, MT Cho, R Willaert, Y Yoo, JH Chae, Y Quan, H Wu, T Wang, RA Bernier, K Xia, A Blesson, M Jain, MM Motazacker, B Jaeger, AL Schneider, K Boysen, AM Muir, CT Myers, RH Gavrilova, L Gunderson, L Schultz-Rogers, EW Klee, D Dyment, M Osmond, M Parellada, C Llorente, J Gonzalez-Peñas, A Carracedo, A Van Haeringen, C Ruivenkamp, C Nava, D Heron, R Nardello, M Iacomino, C Minetti, A Skabar, A Fabretto; SYNaPS Study Group, M Raspall-Chaure, M Chez, A Tsai, E Fassi, M Shinawi, JN Constantino, R De Zorzi, S Fortuna, F Kok, B Keren, D Bonneau, M Choi, B Benzeev, F Zara, HC Mefford, IE Scheffer, J Clayton-Smith, A Macaya, JE Rothman, EE Eichler, DM Kullmann, H Houlden. Member of SYNaPS Study Group. AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders. Nat Commun 2019;10:3094.
https://doi.org/10.1038/s41467-019-10910-w
18. M Breza, G Koutsis, J Tzartos, G Velonakis, ME Evangelopoulos, D Tzanetakos, K Karageorgou, G Angelopoulou, D Kasselimis, C Potagas, M Anagnostouli, L Stefanis, C Kilidireas. Response to correspondence: Testing for myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in typical MS. Mult Scler Relat Disord 2019;35:156-157.
https://doi.org/10.1016/j.msard.2019.07.018
19. S Efthymiou S, V Salpietro, N Malintan, M Poncelet, Y Kriouile, S Fortuna, R De Zorzi, K Payne, LB Henderson, A Cortese, S Maddirevula, N Alhashmi, S Wiethoff, M Ryten, JA Botia, V Provitera, M Schuelke, J Vandrovcova; SYNAPS Study Group, L Walsh, E Torti, V Iodice, M Najafi, EG Karimiani, R Maroofian, K Siquier-Pernet, N Boddaert, P De Lonlay, V Cantagrel, M Aguennouz, M El Khorassani, M Schmidts, FS Alkuraya, S Edvardson, M Nolano, J Devaux, H Houlden. Μember of SYNaPS Study Group. Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination. Brain 2019;142:2948-2964.
20. J Tzartos, K Karagiorgou, D Tzanetakos, M Breza, ME Evangelopoulos, SH Pelidou, C Bakirtzis, I Nikolaidis, G Koutsis, K Notas, E Chroni, J Markakis, KN Grigoriadis, M Anagnostouli, A Orologas, D Parisis, T Karapanayiotides, D Papadimitriou, V Kostadima, J Eloul, J Xidakis, T Maris, P Zisimopoulou, S Tzartos, C Kilindireas. Deciphering anti-MOG IgG antibodies: clinical and radiological spectrum, and comparison of antibody detection assays. J Neurol Sci 2020 Eur J Neurol 2020 Apr 4.
21. D Kasselimis, G Karadima, G Angelopoulou, M Breza, D Tsolakopoulos, C Potagas, M Panas, G Koutsis. Evidence for cognitive deficits in X-linked Charcot-Marie-Tooth disease. J Int Neuropsychol Soc 2020 (in press).
https://doi.org/10.1017/S1355617719001188
22. M Katsari, D Kasselimis, E Giogkaraki, M Breza, ME Evangelopoulos, M Anagnostouli, E Andreadou, C Kilidireas, A Hotary, I Zalonis, G Koutsis, C Potagas. A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?. J Neurol 2020 May;267(5):1464-1475.
https://doi.org/10.1007/s00415-020-09720-8
23. M Breza, E Emmanouilidu, E Leandrou, C Kartanou, A Bougea, M Panas, L Stefanis, G Karadima, K Vekrellis, G Koutsis. Elevated serum α-synuclein levels in Huntington’s disease patients. Neuroscience 2020 Apr 1;431:34-39
https://doi.org/10.1016/j.neuroscience.2020.01.037
24. A Papa, J Tzartos, G Sakoutis, E Dardiotis, E Alexiou, M Breza, G Velonakis, P Papamichalis, D Mpampalis, A Komnos, A Karagiorgou, A Papakonstantinou, C Kilidireas, G.M Hadjigeorgiou. Black holes and high levels of neurofilaments in glial fibrillary acidic protein (GFAP) - astrocytopathy: a case report. Eur J Neurol 2020 Apr 4.
https://doi.org/10.1111/ene.14244
25. L.V. Schottlaender, R Abeti, Z Jaunmuktane, C Macmillan, V Chelban, B O’Callaghan, J McKinley, R Maroofian, S Efthymiou, A Athanasiou-Fragkouli, R Forbes, M P.M. Soutar, JH. Livingston, B Kalmar, O Swayne, G Hotton, S Groppa, B Marinova Karashova, W Nachbauer, S Boesch, L Arning, D Timmann, B Cormand, B Pérez-Dueñas, G Di Rosa, J S. Goraya, T Sultan, J Mine, D Avdjieva, H Kathom, R Tincheva, S Banu, M Pineda-Marfa, P Veggiotti, MD. Ferrari, A Verrotti, G Marseglia, SSavasta, M García-Silva, A Macaya Ruiz, B Garavaglia, E Borgione, S Portaro, B Monteagudo Sanchez, R Boles, S Papacostas, M Vikelis, E Zamba Papanicolaou, E Dardiotis, S Maqbool, Sh Ibrahim, S Kirmani, N Noureen Rana, O Atawneh, G Koutsis, M Breza, S Mangano, C Scuderi, E Borgione, G Morello, T Stojkovic, M Zollo, G Heimer, YA. Dauvilliers, P Striano, I Al- Khawaja, F Al-Mutairi, H Sherifa, A Pittman, J Ricardo Mendes de Oliveira, M de Grandis, A Richard-Loendt, F Launchbury, J Althonayan, G McDonnell, A Carr, S Khan, Ch Beetz, A Bisgin, S Tug Bozdogan, A Begtrup, E Torti, L Greensmith, P Giunti, PJ Morrison, S Brandner, M Aurrand-Lions, H Houlden. Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification. The American Journal of Human Genetics 2020; 412-421.
26. M Breza, T Bourinaris, S Efthymiou, R Maroofian, A.A Fragkouli, J Tzartos, G Velonakis, E Karavasilis, G Angelopoulou, D Kasselimis, C Potagas, L Stefanis, G Karadima, G Koutsis, H Houlden. A homozygous GDAP2 loss-of-function variant in a patient with adult-onset cerebellar ataxia. Brain 2020. Jun 1;143(6):e49.
https://doi.org/10.1093/brain/awaa120
27. N Kleineberg, M van der Meulen, C Franke, L Klingelhoefer , A Sauerbier , G Di Liberto , V Carvalho , H W. Berendse , G Deuschl, the RRFS national representatives’ network. Differences in neurology residency training programmes across Europe – a survey among EAN-RRFS national representatives. Eur J Neurol 2020 Aug;27(8):1356-1363.
https://doi.org/10.1111/ene.14242
28. Aigli G. Vakrakou, Dimitrios Tzanetakos, Theodore Argyrakos, Georgios Koutsis, Maria-Eleptheria Evangelopoulos, Elisabeth Andreadou, Maria Anagnostouli, Marianthi Breza, John S. Tzartos, Elias Gialafos, Antonios N. Dimitrakopoulos, Georgios Velonakis, Panagiotis Toulas, Leonidas Stefanis and Constantinos Kilidireas. Recurrent Fulminant Tumefactive Demyelination with Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature, 2020 Jun 30;11:536.
https://doi.org/10.3389/fneur.2020.00536
29. A Laskaratos, M Breza, G Karadima, G Koutsis. Wide range of reduced penetrance alleles in spinal and bulbar muscular atrophy: a model-based approach. J Med Genet. 2020 Jun 22;jmedgenet-2020-106963.
https://doi.org/10.1136/jmedgenet-2020-106963
30. S Ravanidis, A Bougea, N Papagiannakis, Ch Koros, A Simitsi, I Pachi, M Breza, L Stefanis, E Doxakis. Validation of Differentially Expressed Brain-Enriched microRNAs in the Plasma of Parkinson’s Disease Patients. Annals of Clinical and Translational Neurology, 2020 (in press).
https://doi.org/10.1002/acn3.51146
31. Neuray C, Maroofian R, Scala M, Sultan T, Pai GS, Mojarrad M, Khashab HE, deHoll L, Yue W, Alsaif HS, Zanetti MN, Bello O, Person R, Eslahi A, Khazaei Z, Feizabadi MH, Efthymiou S; SYNaPS Study Group, El-Bassyouni HT, Soliman DR, Tekes S, Ozer L, Baltaci V, Khan S, Beetz C, Amr KS, Salpietro V, Jamshidi Y, Alkuraya FS, Houlden H. Early-infantile onset epilepsy and developmental delay caused by bi-allelic GAD1 variants. Brain. 2020 Aug 1;143(8):2388-2397.
https://doi.org/10.1093/brain/awaa178
32. M Breza, J Hirst, V Chelban, G Banneau, L Tissier, B Kol, Th Bourinaris, SA Said, Y Péréon, A Heinzmann, R Debs, R Juntas- Morales, VG Martinez, JP Camdessanche, C Scherer-Gagou, JM Zola, A Athanasiou-Fragkouli, S Efthymiou, G Vavougios, G Velonakis, M Stamelou, J Tzartos, C Potagas, T Zambelis, C Mariotti, C Blackstone, J Vandrovcova, T Mavridis, C Kartanou, L Stefanis, N Wood, G Karadima, E LeGuern, G Koutsis, H Houlden, G Stevanin. Expanding the Spectrum of AP5Z1-Related Hereditary Spastic Paraplegia (HSP-SPG48): A Multicenter Study on a Rare Disease. Mov Disord. 2021 Feb 5.
https://doi.org/10.1002/mds.28487
33. M Breza*, V Kotsali-Peteinelli*, I Tsantzali, A Mavromatos, E Strataki, A Bonakis, G P. Paraskevas, V C. Constantinides, L Stefanis, K Voumvourakis, E Boviatsis, G Tsivgoulis, E Kapaki. Diffuse Glioma manifesting as Normal Pressure Hydrocephalus: A potential pitfall in diagnosis-a case report.
34. Poole OV, Pizzamiglio C, Murphy D, Falabella M, Macken WL, Bugiardini E, Woodward CE, Labrum R, Efthymiou S, Salpietro V, Chelban V, Kaiyrzhanov R, Maroofian R; SYNaPS Study Group, Amato AA, Gregory A, Hayflick SJ, Genomics QS, Jonvik H,Wood N, Houlden H, Vandrovcova J, Hanna MG, Pittman A, Pitceathly RDS. Mitochondrial DNA analysis from exome sequencing data improves the diagnostic yield in neurological diseases. Ann Neurol. 2021 Mar 11. doi: 10.1002/ana.26063. Online ahead of print.
35. V Chelban*, M Breza*, M Szaruga, J Vandrovcova, D Murphy, Ch. J. Lee, S Alikhwan, Th Bourinaris, G Vavougios, M Ilyas, S A. Halim, A Al-Harrasi, Ch Kartanou, C Ronald, I Blumcke, A Alexoudi, St Gatzonis, L Stefanis, G Karadima, N W. Wood, L Chávez-Gutiérrez, J Hardy, H Houlden*, Georgios Koutsis* Spastic paraplegia preceding PSEN1-related familial Alzheimer’s disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (accepted).
36. Mavridis T, Breza M, Deligianni C, Mitsikostas DD. Current advances in the management of cluster headaches.Expert Opin Pharmacother. 2021 Oct;22(14):1931-1943. doi: 10.1080/14656566.2021.1924148. Epub 2021 May 14.
37. Mavridis T, Deligianni CI, Karagiorgis G, Daponte A, Breza M, Mitsikostas DD.Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence-What Do We Know So Far? Pharmaceuticals (Basel). 2021 Jul 20;14(7):700. doi: 10.3390/ph14070700.
38. Tzanetakos D, Tzartos JS, Vakrakou AG, Breza M, Velonakis G, Stathopoulos P, Pantou E, Markakis I, Papadimitriou D, Karavasilis E, Toulas P, Evangelopoulos ΜE, Koutsis G, Anagnostouli M, Stefanis L, Kilidireas C. Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.Mult Scler. 2021 Aug 19:13524585211034362. doi: 10.1177/13524585211034362. Online ahead of print.
39. Karavasilis E, Christidi F, Pantou E, Angelopoulou G, Kasselimis D, Breza M, Kontogeorgiou Z, Filippiadis D, Potagas C, Karadima G, Koutsis G, Velonakis G. Structural and functional brain changes in X-linked Charcot-Marie-Tooth disease: insights from a multimodal neuroimaging study. Neuroradiology. 2021 Sep 9. doi: 10.1007/s00234-021-02730-x. Online ahead of print.
40. Sokratous M, Breza M, Senkevich K, Gan-Or Z, Kalampokini S, Spanaki C, Provatas A, Zaunmuktane Z, Valotassiou V, Georgoulias P, Efthymiou S, Hadjigeorgiou GM, Houlden H, Xiromerisiou G.α-Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism. Mov Disord. 2021 Sep;36(9):2209-2212. doi: 10.1002/mds.28735.
41. Reetz K, Dogan I, Hilgers RD, Giunti P, Parkinson MH, Mariotti C, Nanetti L, Durr A, Ewenczyk C, Boesch S, Nachbauer W, Klopstock T, Stendel C, Rodríguez de Rivera Garrido FJ, Rummey C, Schöls L, Hayer SN, Klockgether T, Giordano I, Didszun C, Rai M, Pandolfo M, Schulz JB; EFACTS study group. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study. Lancet Neurol. 2021 May;20(5):362-372. doi: 10.1016/S1474-4422(21)00027-2. Epub 2021 Mar 23.
42. Kontogeorgiou Z, Voudommatis C, Kartanou C, Pandis D, Breza M, Zambelis T, Stefanis L, Panas M, Koutsis G, Karadima G. HINT1-related neuropathy in Greek patients with Charcot-Marie-Tooth disease. J Peripher Nerv Syst. 2021 Dec;26(4):444-448. doi: 10.1111/jns.12473. Epub 2021 Oct 29.
43. Koutsis G, Kastritis E, Kontogeorgiou Z, Kartanou C, Kokotis P, Rentzos M, Breza M, Kleopa KA, Christodoulou K, Oikonomou E, Anastasakis A, Angelidakis P, Sarmas I, Kargiotis O, Tzagournissakis M, Zaganas I, Foukarakis E, Sachpekidis V, Papathoma A, Panas M, Stefanis L, Dimopoulos MA, Karadima G. Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country.Neuromuscul Disord. 2021 Dec;31(12):1251-1258. doi: 10.1016/j.nmd.2021.09.008. Epub 2021 Sep 29.
44. Mancuso M, Houlden H, Molnar MJ, Filla A, Breza M, Graessner H, Bassetti CLA, Boesch S.How to approach a neurogenetics diagnosis in different European countries: The European Academy of Neurology Neurogenetics Panel survey.Eur J Neurol. 2022 Jul;29(7):1885-1891. doi: 10.1111/ene.15320. Epub 2022 Mar 22.PMID: 35271759.
45. Karagiorgou K, Dandoulaki M, Mantegazza R, Andreetta F, Furlan R, Lindstrom J, Zisimopoulou P, Chroni E, Kokotis P, Anagnostou E, Tzanetakos D, Breza M, Katsarou Z, Amoiridis G, Mastorodemos V, Bregianni M, Bonakis A, Tsivgoulis G, Voumvourakis K, Tzartos S, Tzartos J.Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy. Neurol Neuroimmunol Neuroinflamm. 2022 Mar 29;9(3):e1162. doi: 10.1212/NXI.0000000000001162. Print 2022 May.
46. Mavridis T, Papagiannakis N, Breza M, Vavougios GD, Patas K, Daponte A, Laskaratos A, Archontakis-Barakakis P, Pantazopoulos I, Mitsikostas DD. B-Cell Targeted Therapies in Patients with Multiple Sclerosis and Incidence of Headache: A Systematic Review and Meta-Analysis.J Pers Med. 2022 Sep 8;12(9):1474. doi: 10.3390/jpm12091474.
47. Tzanetakos D, Breza M, Tzartos JS, Bontzos G, Vakrakou AG, Dermentzoglou A, Gkizis I, Smoustopoulos G, Evangelopoulos ME, Stefanis L, Kilidireas C. Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis.Ther Adv Neurol Disord. 2022 Oct 8;15:17562864221127476. doi: 10.1177/17562864221127476. eCollection 2022.
48. Rossi M, Hamed M, Rodríguez-Antigüedad J, Cornejo-Olivas M, Breza M, Lohmann K, Klein C, Rajalingam R, Marras C, van de Warrenburg BP.Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review.Mov Disord. 2023 Mar;38(3):368-377. doi: 10.1002/mds.29278. Epub 2022 Nov 14.
49. Olszewska DA, Shetty A, Rajalingam R, Rodriguez-Antiguedad J, Hamed M, Huang J, Breza M, Rasheed A, Bahr N, Madoev H, Westenberger A, Trinh J, Lohmann K, Klein C, Marras C, Waln O. Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review. Eur J Neurol. 2023 Oct;30(10):3377-3393. doi: 10.1111/ene.15969. Epub 2023 Jul 17.
50. Porcu L, Fichera M, Nanetti L, Rulli E, Giunti P, Parkinson MH, Durr A, Ewenczyk C, Boesch S, Nachbauer W, Indelicato E, Klopstock T, Stendel C, Rodríguez de Rivera FJ, Schöls L, Fleszar Z, Giordano I, Didszun C, Castaldo A, Rai M, Klockgether T, Pandolfo M, Schulz JB, Reetz K, Mariotti C; EFACTS Study Group. Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset. Ann Clin Transl Neurol. 2023 Nov;10(11):2000-2012. doi: 10.1002/acn3.51886. Epub 2023 Aug 28.